BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 12124943)

  • 1. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice.
    Lécureuil C; Fontaine I; Crepieux P; Guillou F
    Genesis; 2002 Jul; 33(3):114-8. PubMed ID: 12124943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
    Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
    Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin alpha-iCre mice: Cre deleter lines for the gonads, pituitary, and adrenal.
    Jorgez CJ; De Mayo FJ; Matzuk MM
    Genesis; 2006 Apr; 44(4):183-8. PubMed ID: 16604527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
    Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
    Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of keratinocyte-specific Cre recombinase transgenic mice].
    Mao CM; Yang X; Cheng X; Lü YX; Zhou J; Huang CF
    Yi Chuan Xue Bao; 2003 May; 30(5):407-13. PubMed ID: 12924153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thick ascending limb-specific expression of Cre recombinase.
    Stricklett PK; Taylor D; Nelson RD; Kohan DE
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F33-9. PubMed ID: 12644440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrocyte-specific expression of Cre recombinase in transgenic mice.
    Kusakabe T; Kawaguchi A; Kawaguchi R; Feigenbaum L; Kimura S
    Genesis; 2004 Jul; 39(3):212-6. PubMed ID: 15282748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
    Zhou J; Cheng X; Lu YX; Huang CF; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flp recombinase transgenic mice of C57BL/6 strain for conditional gene targeting.
    Takeuchi T; Nomura T; Tsujita M; Suzuki M; Fuse T; Mori H; Mishina M
    Biochem Biophys Res Commun; 2002 May; 293(3):953-7. PubMed ID: 12051751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells.
    Boyer A; Hermo L; Paquet M; Robaire B; Boerboom D
    Biol Reprod; 2008 Sep; 79(3):475-85. PubMed ID: 18480464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.